ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
An open-label study of lamivudine for chronic hepatitis B in six patients with chronic renal failure before and after kidney transplantation
The American Journal of Gastroenterology
◽
10.1111/j.1572-0241.2000.03296.x
◽
2000
◽
Vol 95
(12)
◽
pp. 3579-3583
◽
Cited By ~ 27
Author(s):
Z. Ben-Ari
◽
E. Broida
◽
Y. Kittai
◽
A. Chagnac
◽
R. Tur-Kaspa
Keyword(s):
Renal Failure
◽
Chronic Hepatitis
◽
Kidney Transplantation
◽
Chronic Renal Failure
◽
Hepatitis B
◽
Chronic Hepatitis B
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Before And After
Download Full-text
Related Documents
Cited By
References
Safety and efficacy of switching to tenofovir alafenamide (TAF) in virally suppressed chronic hepatitis B (CHB) patients with renal impairment: week 48 results from a phase 2 open label study
Journal of Hepatology
◽
10.1016/s0168-8278(20)32176-0
◽
2020
◽
Vol 73
◽
pp. S868-S869
Author(s):
Harry Janssen
◽
Pietro Lampertico
◽
Chi-Yi Chen
◽
Jeong Heo
◽
Claire Fournier
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis B
◽
Renal Impairment
◽
Chronic Hepatitis B
◽
Phase 2
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Safety And Efficacy
◽
Tenofovir Alafenamide
Download Full-text
43 A multicenter, randomized, open-label study of peginterferon alpha-2b vs interferon alpha-2b for the treatment of chinese patients with HBeAg+VE chronic hepatitis B
Journal of Hepatology
◽
10.1016/s0168-8278(06)80044-9
◽
2006
◽
Vol 44
◽
pp. S20-S21
◽
Cited By ~ 3
Author(s):
H. Zhao
◽
C.-W. Si
◽
L. Wei
◽
M.-B. Wan
◽
Y.-K. Ying
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis B
◽
Chronic Hepatitis B
◽
Interferon Alpha
◽
Chinese Patients
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Interferon Alpha 2B
Download Full-text
A randomized, open-label study comparing low-dose clevudine plus adefovir combination therapy with clevudine monotherapy in naïve chronic hepatitis B patients
Hepatology International
◽
10.1007/s12072-014-9537-5
◽
2014
◽
Vol 8
(3)
◽
pp. 375-381
◽
Cited By ~ 6
Author(s):
Won Young Tak
◽
Jin Mo Yang
◽
Byung Ik Kim
◽
Soon Koo Baik
◽
Gab Jin Cheon
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis B
◽
Combination Therapy
◽
Chronic Hepatitis B
◽
Low Dose
◽
Open Label
◽
Open Label Study
◽
Label Study
Download Full-text
Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study
Hepatology
◽
10.1002/hep.24361
◽
2011
◽
Vol 54
(1)
◽
pp. 91-100
◽
Cited By ~ 135
Author(s):
Yun-Fan Liaw
◽
Maria Raptopoulou-Gigi
◽
Hugo Cheinquer
◽
Shiv Kumar Sarin
◽
Tawesak Tanwandee
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis B
◽
Chronic Hepatitis B
◽
Efficacy And Safety
◽
Hepatic Decompensation
◽
Open Label
◽
Open Label Study
◽
Label Study
Download Full-text
Sa1522 EFFICACY AND SAFETY OF SWITCHING TO TENOFOVIR ALAFENAMIDE IN VIRALLY SUPPRESSED CHRONIC HEPATITIS B PATIENTS WITH RENAL IMPAIRMENT: WEEK 24 RESULTS FROM A PHASE 2 OPEN-LABEL STUDY
Gastroenterology
◽
10.1016/s0016-5085(20)33967-6
◽
2020
◽
Vol 158
(6)
◽
pp. S-1319-S-1320
Author(s):
Ho Bae
◽
Huy N. Trinh
◽
Harry L. Janssen
◽
Claire Fournier
◽
Wan-Long Chuang
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis B
◽
Renal Impairment
◽
Chronic Hepatitis B
◽
Phase 2
◽
Efficacy And Safety
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Tenofovir Alafenamide
Download Full-text
Efficacy of thymosin α-1 plus peginterferon α-2a combination therapy compared with peginterferon α-2a monotherapy in HBeAg-positive chronic hepatitis B: A prospective, multicenter, randomized, open-label study
Scandinavian Journal of Gastroenterology
◽
10.3109/00365521.2012.694902
◽
2012
◽
Vol 47
(8-9)
◽
pp. 1048-1055
◽
Cited By ~ 15
Author(s):
Bo Hyun Kim
◽
Youn-Jae Lee
◽
Won Kim
◽
Jung-Hwan Yoon
◽
Eun Uk Jung
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis B
◽
Combination Therapy
◽
Chronic Hepatitis B
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Positive Chronic Hepatitis
◽
Peginterferon Α
Download Full-text
Safety and efficacy of switching to tenofovir alafenamide (TAF) in virally suppressed chronic hepatitis B (CHB) patients with hepatic impairment: week 48 results from a phase 2 open label study
Journal of Hepatology
◽
10.1016/s0168-8278(20)32187-5
◽
2020
◽
Vol 73
◽
pp. S872
Author(s):
Young-Suk Lim
◽
Chun-yen Lin
◽
Jeong Heo
◽
Ho Bae
◽
Wan-Long Chuang
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis B
◽
Chronic Hepatitis B
◽
Hepatic Impairment
◽
Phase 2
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Safety And Efficacy
◽
Tenofovir Alafenamide
Download Full-text
S1127 Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) in Virally Suppressed Chronic Hepatitis B (CHB) Patients With Renal Impairment: Week 48 Results From a Phase 2 Open-Label Study
The American Journal of Gastroenterology
◽
10.14309/01.ajg.0000778040.44734.f8
◽
2021
◽
Vol 116
(1)
◽
pp. S530-S530
Author(s):
Harry Janssen
◽
Jeong Heo
◽
Claire Fournier
◽
Sang Hoon Ahn
◽
Carla S. Coffin
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis B
◽
Renal Impairment
◽
Chronic Hepatitis B
◽
Phase 2
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Safety And Efficacy
◽
Tenofovir Alafenamide
Download Full-text
1010 OPTIB – A MULTICENTER PROSPECTIVE OPEN LABEL STUDY ON TENOFOVIR (TDF) FOR CHRONIC HEPATITIS B PATIENTS WITH SUBOPTIMAL RESPONSE TO ADV OR ADV/LAM TREATMENT
Journal of Hepatology
◽
10.1016/s0168-8278(10)61011-2
◽
2010
◽
Vol 52
◽
pp. S390
◽
Cited By ~ 3
Author(s):
M. Levrero
◽
L. Cimino
◽
P. Lampertico
◽
M. Vigano'
◽
G. Gaeta
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis B
◽
Chronic Hepatitis B
◽
Open Label
◽
Open Label Study
◽
Label Study
Download Full-text
Sa1525 SAFETY AND EFFICACY OF SWITCHING TO TENOFOVIR ALAFENAMIDE (TAF) IN VIRALLY SUPPRESSED CHRONIC HEPATITIS B (CHB) PATIENTS WITH HEPATIC IMPAIRMENT: WEEK 24 RESULTS FROM A PHASE 2 OPEN-LABEL STUDY
Gastroenterology
◽
10.1016/s0016-5085(20)33970-6
◽
2020
◽
Vol 158
(6)
◽
pp. S-1320-S-1321
Author(s):
Carla Coffin
◽
Young-Suk Lim
◽
Ho Bae
◽
Jeong Heo
◽
Aric J Hui
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis B
◽
Chronic Hepatitis B
◽
Hepatic Impairment
◽
Phase 2
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Safety And Efficacy
◽
Tenofovir Alafenamide
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close